Click on a filter below to refine your search. Remove a filter to broaden your search.
Risks for new-onset psychiatric diagnoses and anxiety disorders, but not mood disorders, increased in the early postacute phase.
Individuals with breakthrough infection have an increased risk for death and postacute sequelae compared with contemporary controls.
Improvements were seen in physical and mental health, but survivors still have more symptoms than controls at two years.
Significant improvement was seen in the mental health composite score but not in physical composite score of health-related quality of life.
Evidence shows worse clinical outcomes on day 5 for the intervention group versus the usual-care group.
Demographic characteristics suggestive of less empowerment may increase risk for moral injury.
Healthcare use is projected to normalize after a decline in 2020; remaining federal supplemental spending is expected to decrease through 2024.
The findings were seen among non-critically ill patients with moderate hypoxemia who were admitted to hospital with COVID-19.
The prevalence of symptoms of depression and anxiety increased among those with COVID-19 who were bedridden for more than seven days.
Of 30 patients, 90% survived to discharge; survival was 86.7% at a median follow-up of 10.8 months since ECMO cannulation.